SCHEMBL3177057

SCHEMBL3177057

CC(=O)NCCNc1cc(NC(=O)CN2CCN(c3c(Cl)cncc3Cl)CC2)nc(-c2ccccc2)n1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ AURKA O14965 1/20 0.41
▸ EGFR P00533 3/20 0.40
▸ ALDH1A1 P00352 1/20 0.39
▸ JAK3 P52333 2/20 0.39
▸ JAK2 O60674 1/20 0.39
▸ ADORA3 P0DMS8 4/20 0.39
▸ GFER P55789 1/20 0.39
▸ KDR P35968 2/20 0.39
▸ ADORA2A P29274 3/20 0.38
▸ ADORA1 P30542 3/20 0.38
▸ ADORA2B P29275 2/20 0.38
▸ TSHR P16473 2/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CLK4 Q9HAZ1 1/20 0.38
▸ WNT3A P56704 1/20 0.38
▸ PIM2 Q9P1W9 1/20 0.38
▸ HCAR2 Q8TDS4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3162425 0.87 EGFR (0.53) EGFRALDH1A1JAK3JAK2GFER
SCHEMBL3166360 0.87 HCAR2 (0.42) ALDH1A1ADORA3ADORA2AADORA1ADORA2B
SCHEMBL3162806 0.86 JAK3 (0.51) EGFRALDH1A1JAK3TSHRCYP1A2
SCHEMBL3164831 0.86 MAPT (0.50) EGFRALDH1A1JAK3JAK2KDR
SCHEMBL3160939 0.85 ALDH1A1 (0.52) EGFRALDH1A1ADORA2AADORA1TSHR
SCHEMBL3163746 0.85 ALDH1A1 (0.50) ALDH1A1ADORA3ADORA2AADORA1ADORA2B
SCHEMBL3171920 0.85 ADORA1 (0.47) EGFRALDH1A1ADORA3ADORA2AADORA1
SCHEMBL3162693 0.85 KMT2A (0.43) EGFRALDH1A1ADORA3
SCHEMBL3172939 0.84 DRD2 (0.44) ALDH1A1ADORA2AADORA1TSHRCYP1A2
SCHEMBL3163144 0.84 ADORA3 (0.46) EGFRALDH1A1ADORA3ADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 — — EP disclosed
Send feedback